28.02.2019
- Swiss drugs giant Roche has agreed to pay $4.3 billion for Spark Therapeutics, marking the latest purchase of a biotech company by big pharma. The deal gives Roche the first US...
22.02.2019
- GlaxoSmithKline (GSK) Asia is selling subsidiary Chiron Behring Vaccines to Indian biotechnology company Bharat Biotech for an undisclosed sum. The all-cash transaction, which...
22.02.2019
- Activist shareholder Starboard Value has acquired an interest of 1 million share of Bristol-Myers Squibb (BMS) and has held meetings with management, the US drugmaker said. BMS...
18.02.2019
- Within a week, US biotech Celgene, which is in the process of being acquired by Bristol-Myers-Squibb (BMS), dodged a challenge to its patent for the blockbuster multiple myeloma...
14.02.2019
- US biopharma AbbVie has agreed a deal with Teneobio, a California-based biotech, to develop and commercialize an immunotherapeutic that targets B-cell maturation antigen (BCMA) for...
05.02.2019
- The proposed $74 billion takeover of US biotech Celgene by compatriot BristolMyers Squibb (BMS), announced last month, may be looking somewhat shaky. Analysts and investors up to...
31.01.2019
- Richard Ridinger, CEO of Basel, Switzerland-based fine chemicals producer Lonza since April 2012, will retire at the end of February and be succeeded on Mar. 1 by Marc Funk...
22.01.2019
- Israel’s tax authority is seeking to recover $271 million in retroactive tax for 2014-2015 from drugmaker Teva, reports said. The newspaper Calcalist said Teva, one of the country...
10.01.2019
- France’s Sanofi is paying $462 million to exit the immuno-oncology pact it established with US biotech Regeneron in 2015 half a year earlier than planned. With the severance...
09.01.2019
- In the latest move by “big pharma” to buy into cancer-focused biotechs, US drugmaker Eli Lilly is acquiring Loxo Oncology for about $8 billion in cash. The plans were announced on...
